Med Biogene Stock Technical Analysis

MBGNF Stock  USD 0.01  0.00  0.00%   
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Med BioGene, as well as the relationship between them.

Med BioGene Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Med, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Med
  
Med BioGene's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Please note, there is a significant difference between Med BioGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Med BioGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Med BioGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Med BioGene 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Med BioGene's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Med BioGene.
0.00
10/24/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/22/2026
0.00
If you would invest  0.00  in Med BioGene on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding Med BioGene or generate 0.0% return on investment in Med BioGene over 90 days. Med BioGene is related to or competes with Guided Therapeutics, Nova Leap, and Izotropic. Previously, it was engaged in the life science business with a focus on the development and commercialization of genomic... More

Med BioGene Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Med BioGene's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Med BioGene upside and downside potential and time the market with a certain degree of confidence.

Med BioGene Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Med BioGene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Med BioGene's standard deviation. In reality, there are many statistical measures that can use Med BioGene historical prices to predict the future Med BioGene's volatility.
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.0000.01
Details
Naive
Forecast
LowNextHigh
0.010.010.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details

Med BioGene Backtested Returns

We have found three technical indicators for Med BioGene, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Med BioGene are completely uncorrelated.

Auto-correlation

    
  1.00  

Perfect predictability

Med BioGene has perfect predictability. Overlapping area represents the amount of predictability between Med BioGene time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Med BioGene price movement. The serial correlation of 1.0 indicates that 100.0% of current Med BioGene price fluctuation can be explain by its past prices.
Correlation Coefficient1.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0
Med BioGene technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Med BioGene technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Med BioGene trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Med BioGene Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Med BioGene volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Med BioGene Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Med BioGene on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Med BioGene based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Med BioGene price pattern first instead of the macroeconomic environment surrounding Med BioGene. By analyzing Med BioGene's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Med BioGene's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Med BioGene specific price patterns or momentum indicators. Please read more on our technical analysis page.

Med BioGene January 22, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Med stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Med Pink Sheet analysis

When running Med BioGene's price analysis, check to measure Med BioGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Med BioGene is operating at the current time. Most of Med BioGene's value examination focuses on studying past and present price action to predict the probability of Med BioGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Med BioGene's price. Additionally, you may evaluate how the addition of Med BioGene to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios